Are small-for-gestational-age preterm infants at increased risk of overweight? Statistical pitfalls in overadjusting

Seham Elmrayed1, Amy Metcalfe2, Darren Brenner2

  • 1Department of Community Health Sciences, O'Brien Institute of Public Health, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Seham.elmrayed1@ucalgary.ca.

Insights

Adjusting for body measures like height and weight can falsely link small for gestational age (SGA) infants to later overweight status. These adjustments may create misleading associations, not reflecting a true direct effect.

Area of Science:

  • Pediatric Growth and Development
  • Nutritional Epidemiology
  • Biostatistics

Background:

  • Small for gestational age (SGA) is a predictor of adverse health outcomes.
  • The relationship between SGA and childhood overweight is complex and may be influenced by confounding factors.
  • Body measures at different time points can impact the observed association.

Purpose of the Study:

  • To investigate the impact of adjusting for body measures (height and weight) on the association between SGA and overweight at three years of age.
  • To determine if adjusting for intermediate body measures confounds the relationship between SGA and later overweight status.

Main Methods:

  • Analysis of data from the Preterm Infant Multicenter Growth Study (n=1089).
  • Logistic regression models were used to adjust for confounders, with separate adjustments for weight and height at 21 months.
  • Marginal structural models (MSMs) were employed to estimate the direct effect of SGA on overweight, controlling for body measures.

Main Results:

  • Crude and confounder-adjusted models showed no association between SGA and overweight.
  • Adjusting for height alone showed a positive association (OR: 2.31), while adjusting for weight showed a significant positive association (OR: 6.60).
  • MSMs, which held height and weight constant, found no direct effect of SGA on overweight (OR: 0.83 for height, OR: 0.71 for weight).

Conclusions:

  • Adjusting for body measures can alter the observed association between SGA and overweight.
  • Spurious associations between SGA and overweight can arise from adjusting for intermediate body measures.
  • The direct effect of SGA on overweight at 3 years is not supported when accounting for body measures using MSMs.
Abstract

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
51
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
70
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
15.9K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
925
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
880